Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12390442 | 1.00 | L3MBTL1 (0.52) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL25719461 | 1.00 | L3MBTL1 (0.52) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL25719445 | 0.98 | L3MBTL1 (0.50) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17725433 | 0.89 | MEN1 (0.44) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17725336 | 0.88 | MEN1 (0.61) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL21882422 | 0.87 | MAPT (0.45) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17948162 | 0.87 | ALDH1A1 (0.42) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL21391747 | 0.85 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL22624260 | 0.85 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17948213 | 0.85 | ALDH1A1 (0.44) | L3MBTL1MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10745362-B2 | Heterocyclic compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2020-08-18 | — | — | US | disclosed |
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | LG CHEM, LTD. (KR) | 2019-06-18 | — | — | US | disclosed |
| US-20180127385-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM LTD. (KR) | 2018-05-10 | — | — | US | disclosed |
| US-20180127385-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM LTD. (KR) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10745362-B2 | Heterocyclic compound and organic light emitting device comprising same | CRY1, CRY2, PER2 | L3MBTL1 634/4885MEN1 847/4885KMT2A 714/4885 |
| US-20180127385-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CRY2, PER2 | L3MBTL1 634/4885MEN1 847/4885KMT2A 714/4885 |
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | CRY1, CRY2, NR2E3 | L3MBTL1 775/4885MEN1 810/4885KMT2A 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.